Cargando…
Predicting escitalopram monotherapy response in depression: The role of anterior cingulate cortex
Neuroimaging biomarkers of treatment efficacy can be used to guide personalized treatment in major depressive disorder (MDD). Escitalopram is recommended as first‐line therapy for MDD and severe depression. An interesting hypothesis suggests that the reconfiguration of dynamic brain networks might p...
Autores principales: | Tian, Shui, Sun, Yurong, Shao, Junneng, Zhang, Siqi, Mo, Zhaoqi, Liu, Xiaoxue, Wang, Qiang, Wang, Li, Zhao, Peng, Chattun, Mohammad Ridwan, Yao, Zhijian, Si, Tianmei, Lu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268019/ https://www.ncbi.nlm.nih.gov/pubmed/31758634 http://dx.doi.org/10.1002/hbm.24872 |
Ejemplares similares
-
Functional impairment‐based segmentation of anterior cingulate cortex in depression and its relationship with treatment effects
por: Zhang, Yujie, et al.
Publicado: (2021) -
Prediction of suicidality in bipolar disorder using variability of intrinsic brain activity and machine learning
por: Tian, Shui, et al.
Publicado: (2023) -
TPH-2 Gene Polymorphism in Major Depressive Disorder Patients With Early-Wakening Symptom
por: Tao, Shiwan, et al.
Publicado: (2018) -
The anterior cingulate cortex and pain processing
por: Fuchs, Perry N., et al.
Publicado: (2014) -
Multiple signals in anterior cingulate cortex
por: Kolling, N, et al.
Publicado: (2016)